Essential role for G proteins in prostate cancer cell growth and signaling.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Urology

• Publication date

  2000-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0022-5347(05)66990-XPMID 11061948
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Akt/Protein Kinase B Is Regulated by Autophosphorylation at the Hypothetical PDK-2 Site*

  2000cited by this paper
• PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2.

  1999cited by this paper
• Regulation of tyrosine kinase cascades by G-protein-coupled receptors.

  1999cited by this paper
• Activation of mitogen-activated protein kinase associated with prostate cancer progression.

  1999cited by this paper
• Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.

  1999cited by this paper
• Cell type-specific angiotensin II-evoked signal transduction pathways: critical roles of Gbetagamma subunit, Src family, and Ras in cardiac fibroblasts.

  1998cited by this paper
• Mechanisms and consequences of activation of protein kinase B/Akt.

  1998cited by this paper
• Activation of Akt/Protein Kinase B by G Protein-coupled Receptors

  1998cited by this paper
• G protein-coupled receptor kinases.

  1998cited by this paper
• Characterization of a Novel Subtype of Human G Protein-coupled Receptor for Lysophosphatidic Acid*

  1998cited by this paper
• Activation of mitogen‐activated protein kinases/extracellular signal‐regulated kinases in human hepatocellular carcinoma

  1998cited by this paper
• Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes.

  1998cited by this paper
• The Pathways Connecting G Protein-coupled Receptors to the Nucleus through Divergent Mitogen-activated Protein Kinase Cascades*

  1998cited by this paper
• Essential Role for G Protein-coupled Receptor Endocytosis in the Activation of Mitogen-activated Protein Kinase*

  1998cited by this paper
• G Protein-coupled Receptors

  1998cited by this paper
• Molecular basis for interactions of G protein betagamma subunits with effectors.

  1998cited by this paper
• Cell Type–Specific Angiotensin II–Evoked Signal Transduction Pathways

  1998cited by this paper
• Molecular Basis for Interactions of G Protein βγ Subunits with Effectors

  1998cited by this paper
• Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.

  1997cited by this paper
• Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A

  1997cited by this paper
• The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.

  1997cited by this paper
• Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB

  1997cited by this paper
• Mitogen-activated protein kinase pathways.

  1997cited by this paper
• Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins.

  1997cited by this paper
• Potentiation of beta-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes.

  1997cited by this paper
• PI3K: downstream AKTion blocks apoptosis.

  1997cited by this paper
• Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A.

  1997cited by this paper
• Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors

  1996cited by this paper
• Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)

  1996cited by this paper
• Mitogenic signaling via G protein-coupled receptors.

  1996cited by this paper
• Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy.

  1995cited by this paper
• Cellular expression of the carboxyl terminus of a G protein-coupled receptor kinase attenuates G beta gamma-mediated signaling.

  1994cited by this paper
• Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells.

  1993cited by this paper
• Bombesin stimulates growth of human prostatic cancer cells in vitro

  1990cited by this paper

• GPCR-Gα13 Involvement in Mitochondrial Function, Oxidative Stress, and Prostate Cancer

  2024cites this paper
• A novel GPCR target in correlation with androgen deprivation therapy for prostate cancer drug discovery

  2020cites this paper
• Characterization of G protein β subunit expression of human brain Glioma tumor.

  2020cites this paper
• Novel role of Giα2 in cell migration: Downstream of PI3‐kinase–AKT and Rac1 in prostate cancer cells

  2018cites this paper
• Inhibiting G protein βγ signaling blocks prostate cancer progression and enhances the efficacy of paclitaxel

  2017cites this paper
• A New Generation of FRET Sensors for Robust Measurement of Gαi1, Gαi2 and Gαi3 Activation Kinetics in Single Cells

  2016cites this paper
• Non-androgen Signaling Pathways in Castration-Resistant Prostate Cancer

  2016cites this paper
• Nonreceptor Tyrosine Kinases in Prostate

  2014cites this paper
• Krüppel-like factor 4 mediates lysophosphatidic acid-stimulated migration and proliferation of PC3M prostate cancer cells

  2014cites this paper
• Function and activation mechanism of PLEKHG2, a novel Gbetagamma-activated RhoGEF in leukemia cells

  2013cites this paper
• The Role Of IL-8-Mediated Src Family Kinase Activation In Tumor-Tumor And Tumor-Stromal Interactions In Metastasis Of Prostate Cancer

  2013cites this paper
• The Essential Role of Giα2 in Prostate Cancer Cell Migration

  2012cites this paper
• G Protein β3 subunit gene C825T polymorphism and its association with the presence and clinicopathological characteristics of prostate cancer.

  2012cites this paper
• Targeted Prostate Cancer Chemoprevention Trial with Tocotrienols

  2012cites this paper
• Signaling and Regulation The Essential Role of Gi a 2 in Prostate Cancer Cell Migration

  2012cites this paper
• CXCL13 mediates prostate cancer cell proliferation through JNK signalling and invasion through ERK activation

  2011cites this paper
• Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells.

  2011cites this paper
• A Correction to the Research Article Titled: "Gαi1 and Gαi3 Are Required for Epidermal Growth Factor–Mediated Activation of the Akt-mTORC1 Pathway" by C. Cao, X. Huang, Y. Han, Y. Wan, L. Birnbaumer, G.-S. Feng, J. Marshall, M. Jiang, W.-M. Chu

  2010cites this paper
• Autotaxin and lipid signaling pathways as anticancer targets.

  2010cites this paper
• Discovery of 4-substituted methoxybenzoyl-aryl-thiazole as novel anticancer agents: synthesis, biological evaluation, and structure-activity relationships.

  2009cites this paper
• Gene expression profiles of lysophosphatidic acid‐related molecules in the prostate: Relevance to prostate cancer and benign hyperplasia

  2009cites this paper
• The glutamatergic system expression in human PC-3 and LNCaP prostate cancer cells.

  2009cites this paper
• Leukemia/Lymphoma Related Factor in Human Prostate Carcinoma

  2008cites this paper
• The role of Src in prostate cancer.

  2007cites this paper
• SEX STEROID AND GROWTH FACTOR EXPRESSION IN PROSTATES OF TRANSGENIC MICE EXPOSED TO DIETARY POLYPHENOLS by LEAH COOK CORAL LAMARTINIERE , COMMITTEE CHAIR

  2007cites this paper
• Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alpha.

  2007cites this paper
• Ovarian Cancer G Protein – Coupled Receptor 1, a New Metastasis Suppressor Gene in Prostate Cancer

  2007cites this paper
• Nonreceptor tyrosine kinases in prostate cancer.

  2007cites this paper
• Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer.

  2007cites this paper
• Regulation of interleukin-8 expression in human prostate cancer cells by insulin-like growth factor-I and inflammatory cytokines.

  2007cites this paper
• Leuprorelin acetate affects ERK1/2 activity in prostate cancer cells.

  2006cites this paper
• Expression and function of lysophosphatidic acid LPA1 receptor in prostate cancer cells.

  2006cites this paper
• [Importance of heterotrimeric G proteins in prostate cancer molecular biology].

  2005cites this paper
• Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and epithelial prostate cancer cells

  2005cites this paper
• Critical role of acylglycerol kinase in epidermal growth factor-induced mitogenesis of prostate cancer cells.

  2005cites this paper
• A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cells

  2005cites this paper
• SAR studies of 2-arylthiazolidine-4-carboxylic acid amides: a novel class of cytotoxic agents for prostate cancer.

  2005cites this paper
• Discovery of 2-arylthiazolidine-4-carboxylic acid amides as a new class of cytotoxic agents for prostate cancer.

  2005cites this paper
• Importancia de las proteinas G heterotriméricas en la biología molecular del cáncer de próstata

  2005cites this paper
• Molecular alterations associated with LNCaP cell progression to androgen independence

  2004cites this paper
• Interleukin 6 Mediates the Lysophosphatidic Acid-regulated Cross-talk between Stromal and Epithelial Prostate Cancer Cells*

  2004cites this paper
• Novel therapeutic strategies for androgen-independent prostate cancer: an update.

  2004cites this paper
• The Akt pathway: molecular targets for anti-cancer drug development.

  2004cites this paper
• p42/p44 Mitogen‐Activated Protein Kinase Signal Transduction Pathway: A Novel Target for the Treatment of Hormone‐Resistant Prostate Cancer?

  2004cites this paper
• Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy

  2004cites this paper
• Lysophosphatidic acid promotes survival of androgen‐insensitive prostate cancer PC3 cells via activation of NF‐κB

  2004cites this paper
• Requirement for G proteins in insulin-like growth factor-I-induced growth of prostate cells.

  2004cites this paper
• G Proteins in Cancer: The Prostate Cancer Paradigm

  2004cites this paper
• The role of G-protein coupled receptors and associated proteins in receptor tyrosine kinase signal transduction.

  2004cites this paper
• Luteinizing hormone-releasing hormone antagonist Cetrorelix regulates the expression of Galphas and Galphai protein subunits and adenylate cyclase activity in rat ovary, breast and pituitary.

  2004cites this paper
• Mitogen Activated Protein kinase signal transduction pathways in the prostate

  2004cites this paper
• Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid.

  2004cites this paper
• Requirement for direct cross-talk between B1 and B2 kinin receptors for the proliferation of androgen-insensitive prostate cancer PC3 cells.

  2003cites this paper
• New Advances on Prostate Carcinogenesis and Therapies: Involvement of EGF-EGFR Transduction System

  2003influential citation
• Targeting Gbetagamma signaling to inhibit prostate tumor formation and growth.

  2003cites this paper
• Signaling in Time and Space: G Protein-Coupled Receptors and Mitogen-Activated Protein Kinases

  2003cites this paper
• Expression of functionally active cannabinoid receptor CB1 in the human prostate gland

  2003cites this paper
• Targeting Gβγ Signaling to Inhibit Prostate Tumor Formation and Growth*

  2003cites this paper
• Synergistic antiproliferative and apoptotic effects induced by epidermal growth factor receptor and protein kinase a inhibitors in human prostatic cancer cell lines

  2003cites this paper
• Bradykinin receptor subtype 1 expression and function in prostate cancer.

  2003cites this paper
• The effect of bone-associated growth factors and cytokines on the growth of prostate cancer cells derived from soft tissue versus bone metastases in vitro.

  2003cites this paper
• Role for 18:1 Lysophosphatidic Acid as an Autocrine Mediator in Prostate Cancer Cells*

  2002cites this paper
• Lysophosphatidic acid‐regulated mitogenic ERK signaling in androgen‐insensitive prostate cancer PC‐3 cells

  2002cites this paper
• Guanosine phosphate binding protein coupled receptors in prostate cancer: a review.

  2002cites this paper
• Lysophosphatidic acid as an autocrine and paracrine mediator.

  2002cites this paper
• Lysophosphatidic Acid and Its Role in Reproduction

  2002influential citation
• 1 Prostate carcinoma: An introduction

  2002cites this paper
• Mitogenic action of LPA in prostate.

  2002cites this paper
• LOW EXPRESSION OF Gα PROTEIN SUBUNITS IN HUMAN PROSTATE CANCER

  2001cites this paper
• Bradykinin induced mitogenesis of androgen independent prostate cancer cells.

  2001cites this paper
• Low expression of Galpha protein subunits in human prostate cancer.

  2001cites this paper
• Number : DAMD 17-021-0060 TITLE : Lysophosphatidic Acid Regulation and Roles in Human Prostate Cancer

  year unknowncites this paper